GLOW (70 mg Vial) Dosage Protocol

GLOW Peptide Blend (70 mg Vial) Dosage Protocol

Quickstart Highlights

GLOW is a research peptide blend combining GHK-Cu, TB-500 (Thymosin Beta-4 fragment), and BPC-157 in one 70 mg vial. Each component has been studied for its regenerative and healing properties across various tissues[1][5]. By delivering all three in one formulation, GLOW aims to synergistically promote tissue repair, inflammation reduction, and wound healing beyond what each peptide might achieve alone.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~23.3 mg/mL concentration.
  • Typical daily dose: 2,330 mcg (2.33 mg) once daily for 4 weeks.
  • Easy measuring: At 23.3 mg/mL, 1 unit = 0.01 mL ≈ 233 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks.
  • GLOW Peptide Blend Vial

    Dosing & Reconstitution Guide

    Educational guide for reconstitution and daily dosing

    Standard Approach (3 mL = 23.3 mg/mL)

    Week Daily Dose (mcg) Units (per injection) (mL)
    Weeks 1–4 2,330 mcg 10 units (0.10 mL)

    Frequency: Inject once daily subcutaneously. This schedule maintains a consistent dose throughout the 4-week cycle, delivering approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection. This once-daily regimen aligns with common research protocols for BPC-157 and similar repair peptides[5][6]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

    Reconstitution Steps

  • Draw 3.0 mL bacteriostatic water with a sterile syringe.
  • Inject slowly down the vial wall to minimize foaming.
  • Gently swirl or roll the vial until fully dissolved (do not shake vigorously).
  • Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  • Use within 4 weeks for optimal potency and safety.
  • Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

    Supplies Needed

    Plan based on a 4-week daily protocol at standard dosing.

  • Peptide Vials (GLOW Blend, 70 mg each):

    • 4 weeks (28 days): 1 vial
  • Insulin Syringes (U-100, preferably 0.3 mL / 30-unit for precision):

    • 4 weeks: 28 syringes (1 per day)
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

    • 4 weeks (1 vial): 3 mL1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

    • 4 weeks: 56 swabs (2 per day) → recommend 1 × 100-count box
  • GLOW Peptide Blend Vial

    View Supplier

    Insulin Syringes

    View Supplier

    Bacteriostatic Water

    View Supplier

    Alcohol Pads

    View Supplier

    Protocol Overview

    Concise summary of the once-daily regenerative blend regimen.

  • Goal: Support comprehensive tissue healing through synergistic peptide mechanisms—collagen synthesis (GHK-Cu), cell migration and angiogenesis (TB-500), and localized repair with anti-inflammatory effects (BPC-157)[1][4][5].
  • Schedule: Daily subcutaneous injections for 4 weeks at a consistent dose, followed by a 2–4 week rest period to assess progress before considering another cycle.
  • Dose: 2,330 mcg (2.33 mg) total blend daily, providing approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection.
  • Reconstitution: 3.0 mL per 70 mg vial (23.3 mg/mL) for precise unit measurements.
  • Storage: Lyophilized vials frozen; reconstituted solutions refrigerated; use within 4 weeks.